Bhagiradha Chemicals & Industries Limited manufactures agrochemical active ingredients and intermediates used in crop-protection products. Its products serve agricultural markets in India and international markets through chemical manufacturing and export operations. The company benefits from demand for crop-protection products and India's role in global agrochemical supply chains. Expansion into additional molecules and value-added products can broaden the business. Raw-material prices, regulatory approvals, export demand, capacity utilization, and global agrochemical cycles remain important considerations.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROE previous year | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹2,678 cr | ₹607 cr | ₹28 cr | 97.4 | 2.12 | 3.84 | 2.6% | 2.5% | 4.5% | 0.33 | ₹-148 cr | 50.0 | 1.04 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 195 | 13 | 1.03 | +232.3% | +57.6% | 6.8% |
| Mar 2026 | 158 | 4 | 0.31 | turnaround | +28.9% | 2.6% |
| Dec 2025 | 114 | 5 | 0.36 | +28.6% | +10.9% | 4.0% |
| Sep 2025 | 140 | 6 | 0.42 | -2.3% | +35.1% | 3.9% |
| Jun 2025 | 124 | 4 | 0.31 | -38.0% | +11.1% | 3.2% |
| Mar 2025 | 123 | -1 | -0.08 | -111.6% | +10.2% | -0.7% |
| Dec 2024 | 103 | 4 | 0.28 | -12.2% | +38.1% | 3.5% |
| Sep 2024 | 104 | 5 | 0.43 | -21.8% | -15.0% | 5.2% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✓ Pass |
| EPS growth accelerating over 3 quarters | — Not assessable |
| Sales up 25%+, or sales growth accelerating | ✓ Pass |
| Annual EPS up 25%+ in each of the last 2 years | ✗ Fail |
| Net margin above the same quarter last year | ✓ Pass |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✗ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✗ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 171.47 ✗ Within 25% of the 52-week high · high 301.25 ✗ RS percentile 70 or more · RS 25 Trend template - the gate, measured: a modest 21-day edge. | 2/8 | 2 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 1 - basing | |
| CAN SLIM | ✓ C latest quarter EPS up 25%+ ✗ A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 301.25 ✗ S more volume on up days than down days (50 sessions) · 0.35x ✗ L RS percentile 80 or more · RS 25 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 2/6 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 316.90 ✗ Close above the prior 20-session high · 251.95 ✓ Close below the prior 20-session low · 211.25 Donchian channel breakout - the Turtle traders' entry. | Breakdown | |
| Greenblatt | — Earnings yield (EBITDA / EV) · 2.0% — Return on capital (ROCE) · 4.5% Joel Greenblatt's Magic Formula: good businesses at good prices, ranked across all companies. Earnings yield uses EBITDA, as EBIT is not held separately. | 4/100 | Weak |
| Graham | ✗ Price at or below the Graham number · Graham number 50.65 ✗ P/E 15 or less · P/E 97.4 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 3.84 ✗ Current ratio 2 or more · 1.78 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 25/100 | Expensive |
| Piotroski | ✓ Profitable (ROA > 0) ✓ Operating cash flow positive ✓ ROA rising ✗ Cash flow above net profit (earnings quality) ✗ Long-term debt / assets falling ✗ Current ratio rising · 1.78 ✓ No new shares issued ✓ Margin rising (net margin) ✓ Asset turnover rising Joseph Piotroski's F-score, FY 2025 -> 2026. | 6/9 | Average |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BHAGCHEM this stock | -16.3 | -25.0 | -12.6 | -15.5 | +29.7 | +156.1 | 97.4 | 3.84 | 2.6 | 4.5 | — | 0.33 | 50.0 | 2,678 | 607 | 28 | 2.1 | 1.04 |
| GCSL | +18.5 | +41.1 | +107.8 | +232.3 | — | — | 47.5 | 7.18 | 19.8 | — | — | 0.04 | 41.4 | 1,770 | 194 | 40 | 15.4 | 0.38 |
| AEROFLEX | -1.1 | +24.4 | +67.9 | +198.2 | +195.5 | — | 97.9 | 14.95 | 14.1 | 19.0 | — | 0.00 | 68.7 | 6,685 | 503 | 67 | 5.2 | 1.58 |
| SPECTRUM | +21.2 | +90.7 | +217.6 | +179.9 | — | — | 100.6 | 23.68 | 20.4 | 17.7 | — | 0.90 | 72.4 | 5,788 | 680 | 58 | 36.6 | -0.04 |
| KESORAMIND | +6.7 | +9.5 | +20.1 | +141.8 | +217.1 | +301.2 | — | 1.07 | -21.5 | -10.3 | — | 0.59 | — | 396 | 325 | -108 | -3.5 | 0.98 |
| KANORICHEM | -3.1 | +21.9 | +130.6 | +124.6 | +36.1 | -3.5 | 5.0 | 1.36 | 27.6 | 6.0 | — | 0.51 | 11.7 | 779 | 1,240 | 153 | 35.5 | 1.41 |
| MANINDS | +3.9 | +65.1 | +65.1 | +122.3 | +287.1 | +712.2 | 32.0 | 3.18 | 9.2 | 16.7 | — | 0.24 | 14.5 | 6,634 | 3,875 | 204 | 27.7 | 1.96 |
| YASHO | -11.7 | +15.0 | +138.1 | +121.4 | +100.8 | — | 69.5 | 9.60 | 5.8 | 9.1 | — | 1.22 | 34.0 | 4,260 | 1,138 | 61 | 50.9 | 0.95 |
| SMARTLINK | +16.6 | +19.4 | +84.4 | +97.8 | +45.0 | +114.7 | — | 1.22 | — | — | — | — | — | — | — | — | — | 0.70 |
| MMP | +2.5 | +68.2 | +89.8 | +82.1 | +120.3 | +222.2 | 24.2 | 3.51 | 9.3 | 8.9 | — | 0.53 | 25.3 | 1,215 | 873 | 50 | 19.7 | 1.08 |
| DOLPHIN | -5.2 | +66.8 | +56.7 | +64.9 | +1168.7 | — | 35.0 | 7.14 | 25.9 | 14.9 | — | 0.57 | 31.2 | 2,523 | 143 | 72 | 18.0 | 0.47 |